Q2B25 Silicon Valley | Phalgun Lolur, Capgemini with Mykola Maksymenko, Haiqu @QCWare

Q2B25 Silicon Valley | Phalgun Lolur, Capgemini with Mykola Maksymenko, Haiqu @QCWare

Uploaded January 2026 | Updated September 2026, 2 weeks ago

Scaling Reactivity Prediction for Drug Candidates: A Real-World Case-Study |
Phalgun Lolur, Global Scientific Quantum Development Lead, Capgemini and
Mykola Maksymenko, CTO & Co founder, Haiqu

q2b.qcware.com

Q2B25 Silicon Valley | Phalgun Lolur, Capgemini with Mykola Maksymenko, Haiqu

Q2B26 Tokyo | Genki Okano, Classiq Technologies; Ang Li, Macnica and Fei Bao, Macnica

Q2B26 Tokyo | A Global Hub for Quantum Business: The Future of Tokyo

Q2B25 Silicon Valley | Dr. Yuping Huang, CEO, QCi

Q2B25 Paris | Hyunsik Yang, Pro, Norma

Q2B26 Tokyo | Xinchi Huang (黄欣馳), Quemix, Inc. and Masanobu Uchimura (内村允宣), Nissan Motor Co., Ltd.

Q2B25 Silicon Valley | Pranav Gokhale, CTO, Infleqtion

Q2B25 Silicon Valley | Entropy Quantum Computing For Fixed-Backbone Protein Design

Q2B25 Paris | Joseph Mikael, Head of Quantum Computation, EDF

Q2B25 Paris | Dr. Michael Hayduk, Deputy Director, Information Directorate, AFRL

Q2B26 Tokyo | Nobushige Oguri, General Manager, Softbank Corp.

Q2B26 Tokyo | Taro Shimada, Chair of the Board, Q-STAR

Q2B25 Silicon Valley | Phalgun Lolur, Capgemini with Mykola Maksymenko, Haiqu